FIELD: medicine.
SUBSTANCE: invention represents a method of differential diagnostics of chronic viral hepatitis and fatty liver disease in patients with dyslipidemia syndrome, consisting in the following: activity of the glutathione reductase antioxidant system enzyme (GLR), which is estimated by a spectrophotometric method, is determined in the patient's blood serum, and if GLR value is lower or equals 14.6 mcmol/l/min, the fatty liver disease is diagnosed, if GLR concentration is higher than 14.6 mcmol/l/min, chronic viral hepatitis is diagnosed.
EFFECT: reduction of trauma, increase of availability and simplicity of realisation with high sensitivity, specificity and effectiveness.
4 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR CHRONIC VIRAL HEPATITIS AND FATTY LIVER DISEASE IN PATIENTS SUFFERING DYSLIPIDEMIA SYNDROME | 2014 |
|
RU2542457C1 |
| METHOD OF SCREENING STUDY OF RISK OF DEVELOPING LIVER DAMAGE OF DIFFERENT ORIGINS | 2017 |
|
RU2675015C1 |
| METHOD OF FATTY LIVER DISEASE DIAGNOSTICS IN PATIENTS SUFFERING FROM CHRONIC VIRAL HEPATITIS C | 2006 |
|
RU2347226C2 |
| METHOD FOR VERIFYING CHRONIC HEPATIC PATHOLOGY IN PATIENTS WITH ARTERIAL HYPERTENSION | 2013 |
|
RU2547246C1 |
| METHOD OF PREDICTING EXACERBATION OF CHRONIC HEPATITIS C IN TEENAGE CHILDREN | 2009 |
|
RU2412444C1 |
| METHOD OF EARLY DIAGNOSTICS OF ALCOHOLIC LIVER STEATOSIS IN PATIENTS WITH ALCOHOL DEPENDENCE SYNDROME | 2023 |
|
RU2814909C1 |
| METHOD FOR PREDICTING NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2021 |
|
RU2765848C1 |
| METHOD FOR PREDICTING SEVERE HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2021 |
|
RU2765847C1 |
| METHOD OF DIAGNOSIS OF CHRONIC DISEASES OF LIVER | 0 |
|
SU1142105A1 |
| METHOD FOR TREATING THE CHRONIC VIRAL HEPATITIS C PATIENTS HAVING HEPATIC HEMOSIDEROSIS | 1999 |
|
RU2180599C2 |
